St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.
Vall d'Hebron Research Institute (VHIR) and Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain.
Diabetes Obes Metab. 2019 Mar;21(3):467-478. doi: 10.1111/dom.13550. Epub 2018 Oct 29.
The aim of this systematic review was to examine the associations between diabetic retinopathy (DR) and the common micro- and macrovascular complications of diabetes mellitus, and how these could potentially affect clinical practice. A structured search of the PubMed database identified studies of patients with diabetes that assessed the presence or development of DR in conjunction with other vascular complications of diabetes. From 70 included studies, we found that DR is consistently associated with other complications of diabetes, with the severity of DR linked to a higher risk of the presence of, or of developing, other micro- and macrovascular complications. In particular, DR increases the likelihood of having or developing nephropathy and is also a strong predictor of stroke and cardiovascular disease, and progression of DR significantly increases this risk. Proliferative DR is a strong risk factor for peripheral arterial disease, which carries a risk of lower extremity ulceration and amputation. Additionally, our findings suggest that a patient with DR has an overall worse prognosis than a patient without DR. In conclusion, this analysis highlights the need for a coordinated and collaborative approach to patient management. Given the widespread use of DR screening programmes that can be performed outside of an ophthalmology office, and the overall cost-effectiveness of DR screening, the presence and severity of DR can be a means of identifying patients at increased risk for micro- and macrovascular complications, enabling earlier detection, referral and intervention with the aim of reducing morbidity and mortality among patients with diabetes. Healthcare professionals involved in the management of diabetes should encourage regular DR screening.
本系统评价的目的是研究糖尿病视网膜病变 (DR) 与糖尿病常见的微血管和大血管并发症之间的关联,以及这些关联如何影响临床实践。通过对 PubMed 数据库进行有组织的搜索,确定了评估糖尿病患者是否存在或发展 DR 与糖尿病其他血管并发症之间关系的研究。在纳入的 70 项研究中,我们发现 DR 与糖尿病的其他并发症密切相关,DR 的严重程度与其他微血管和大血管并发症的存在或发展风险增加相关。特别是,DR 增加了发生或发展肾病的可能性,也是中风和心血管疾病的强烈预测因素,DR 的进展显著增加了这种风险。增生性 DR 是外周动脉疾病的强烈危险因素,外周动脉疾病会导致下肢溃疡和截肢。此外,我们的研究结果表明,患有 DR 的患者的总体预后比没有 DR 的患者差。总之,这项分析强调了需要采取协调一致的方法来管理患者。鉴于可以在眼科诊所之外进行的广泛使用的 DR 筛查计划,以及 DR 筛查的总体成本效益,DR 的存在和严重程度可以作为识别微血管和大血管并发症风险增加的患者的一种手段,从而实现早期检测、转诊和干预,以降低糖尿病患者的发病率和死亡率。参与糖尿病管理的医疗保健专业人员应鼓励定期进行 DR 筛查。